CDSCO UID IMP/IVD/2023/000036_c2d3f1f013c4468c98100037868ae867_72a369760b3f3b900a0a005ed97367f9Anti-HBe (MAGLUMI® Anti-HBe )
- UID
- IMP/IVD/2023/000036_c2d3f1f013c4468c98100037868ae867_72a369760b3f3b900a0a005ed97367f9
- Device class
- Class C
- Brand name
- CLIA
- License holder
- SNIBE DIAGNOSTIC (India) Private Limited.
- Approving authority
- CDSCO
- Product information
- The kit is an in vitro chemiluminescence immunoassay for the qualitative determination of Anti-HBe in human serum and plasma using the MAGLUMI series Fully-auto chemiluminescence immunoassay analyzer and Biolumi series Integrated System, and the assay is used as an aid in the diagnosis of HBV infection
Anti-HBe (MAGLUMI® Anti-HBe ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000036_c2d3f1f013c4468c98100037868ae867_72a369760b3f3b900a0a005ed97367f9. This device is marketed under the brand name CLIA. The license holder is SNIBE DIAGNOSTIC (India) Private Limited., and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides the facts attached to this CDSCO registry row. Other records from the same license holder are available through the database search link without adding aggregation queries to this page. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.